NCT01774045View on ClinicalTrials.gov

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

PDC-1421

DRUG

Placebo

Trial Locations (1)

112

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

BioLite, Inc.

INDUSTRY

NCT01774045 - A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression | Biotech Hunter | Biotech Hunter